Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: lrb who wrote (603)	2/5/1999 1:22:00 AM
From: scaram(o)uche	Respond to of 2001

from the S-3....... APPROXIMATE NUMBER OF SURGERIES PERFORMED PRODUCT SURGICAL APPLICATION STATUS(1) ANNUALLY IN THE U.S. - ------------------------------------------------------------------------------------------------------ <S> <C> <C> <C> <C> ADCON-L Lumbar surgeries Approvable letter received from 450,000 the FDA in April 1998 Marketed in 29 countries outside the U.S. ADCON-P Pelvic/gynecological U.S. pilot clinical trials 1,300,000 surgeries underway ADCON-T/N Tendon and peripheral U.S. pivotal clinical trials 260,000 nerve surgeries of the underway hand Marketed in 29 countries outside the U.S. ADCON-A Abdominal surgeries Preclinical research 2,500,000 ADCON-I Implant/prosthetic Preclinical research 1,400,000 surgeries ADCON-C Cardiac surgeries Preclinical research 1,000,000